Improved Survival After Acute Myocardial Infarction Complicated by Cardiogenic Shock With Circulatory Support and Transplantation: Comparing Aggressive Intervention With Conservative Treatment

Journal of Heart and Lung Transplantation

Volumn 25, Issue 5, 2006, Pages 504-509

  Tayara, Wakkas ^a   Starling, Randall C ^a   Yamani, Mohamad H ^a   Wazni, Oussama ^a   Jubran, Fuad ^a   Smedira, Nicholas ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; AORTA BALLOON; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; FEMALE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; SURVIVAL; SURVIVAL TIME; TIME SERIES ANALYSIS; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FIBRINOLYTIC THERAPY; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART TRANSPLANTATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY;

EID: 33745942850     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.10.011     Document Type: Article

References (48)

1. Goldberg R.J., Gore J.M., Alpert J.S., et al. Cardiogenic shock after acute myocardial infarction. incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 325 (1991) 117-122
2. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634
3. Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA 285 (2001) 190-192
4. Hollenberg S.M., Kavinsky C.J., and Parillo J.E. Cardiogenic shock. Ann Intern Med 131 (1999) 47-59
5. Wilcox R.G., von der Lippe G., Olsson C.G., et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 2 (1988) 525-530
6. Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2. Lancet 2 (1988) 349-360
7. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
8. Holmes Jr. D.R., Bates E.R., Kleiman N.S., et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. JAMA 26 (1995) 668-674
9. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction. preliminary report of a placebo controlled clinical trial. Lancet 1 (1988) 545-549
10. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
11. Grines C.L., Browne K.F., Marco J., et al., The Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
12. Gibbons R.J., Holmes D.R., Reeder G.S., et al., The Mayo Coronary Care Unit and Catheterization Laboratory Groups. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment of myocardial infarction. N Engl J Med 328 (1993) 685-691
13. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase 1 findings. N Engl J Med 312 (1985) 932-936
14. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110 (2004) 588-636
15. Babaev A., Frederick P.D., Pasta D., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 (2005) 448-454
16. Hosenpud J.D., Bennett L.E., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation. sixteenth official report-1999. J Heart Lung Transplant 18 (1999) 611-626
17. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
18. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. J Am Coll Cardiol 46 (2005) 1116-1143
19. Kherani A.R., Maybaum S., and Oz M.C. Ventricular assist devices as a bridge to transplant or recovery. Cardiology 101 (2004) 93-103
20. Col N., Gurwitz J., Alpert J., and Goldberg R. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol 73 (1994) 149-157
21. Dioguardi N., Lotto A., Levi G., et al. Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet 2 (1971) 891-895
22. Mathey D., Kuck K.H., Tilsner V., et al. Nonsurgical coronary artery recanalization in acute transmural myocardial infarction. Circulation 63 (1982) 489-497
23. Kennedy J.W., Gensini G.G., Timmis G.C., and Maynard C. Acute myocardial infarction treated with intracoronary streptokinase. a report of the Society for Cardiac Angiography. Am J Cardiol 55 (1985) 871-877
24. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction. collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343 (1994) 311-322
25. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1 (1986) 397-401
26. Menon V., Hochman J.S., Stebbins A., et al. Lack of progress in cardiogenic shock. lessons from the GUSTO trials. [see comment]. [Multicenter Study] European Heart Journal 21 (2000) 1928-1936
27. Shawl F.A., Domanski M.J., Hernandez T.J., and Punja S. Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction. Am J Cardiol 64 (1989) 967-970
28. O'Neill W.W., Embel R., Laufer N., et al. Coronary angioplasty therapy of cardiogenic shock complicating acute myocardial infarction. Circulation 72 suppl III (1985) III-309
29. O'Keefe Jr. J.H., Bailey W.L., Rutherford B.D., and Hartzler G.O. Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. Am J Cardiol 72 (1993) 107G-115G
30. Califf R.M., and Bengtson J.R. Cardiogenic shock. N Engl J Med 330 (1994) 1724-1730
31. Bengtson J.R., Kaplan A.J., Pieper K.S., et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. JAMA 20 (1992) 1482-1489
32. Grines C.L., Browne K.F., Marco J., et al., The Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
33. Gacioch G.M., Ellis S.G., Lee L., et al. Cardiogenic shock complicating acute myocardial infarction. the use of coronary angioplasty and the integration of the new support devices into patient management. JAMA 19 (1992) 647-653
34. De Wood M.A., Notske R.N., Hensley G.R., et al. Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 61 (1980) 1105-1112
35. Kirklin J.K., Blackstone E.H., Zorn G.L., et al. Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction. Circulation 72 suppl II (1985) II-175-II-178
36. Phillips S.J., Kongtahworn C., Skinner J.R., and Zeff R.H. Emergency coronary artery reperfusion. A choice therapy for evolving myocardial infarction: results in 339 patients. J Thorac Cardiovasc Surg 86 (1983) 679-688
37. Laks H., Rosenkranz E., and Buckberg G.D. Surgical treatment of cardiogenic shock after myocardial infarction. Circulation 74 suppl III (1986) III-11-III-16
38. Frazier O.H., Rose E.A., McCarthy P., et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 222 (1995) 327-338
39. McCarthy P.M., Smedira N.G., Vargo R.L., et al. One-hundred patients with the HeartMate left ventricular assist device. evolving concepts and technology. J Thorac Cardiovasc Surg 115 (1998) 904-912
40. Frazier O.H., Macris M.P., Myers T.J., et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 57 (1994) 1416-1422
41. Oz M.C., Rose E.A., and Levin H.R. Selection criteria for placement of left ventricular assist devices. Am Heart J 129 (1995) 173-177
42. Oz M.C., Goldstein D.J., Pepino P., et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 92 suppl II (1995) II-169-II-173
43. Park S.J., Nguyen D.Q., Bank A.H., et al. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg 69 (2000) 1146-1151
44. Chen J.M., DeRose J.J., Slater J.P., et al. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol 33 (1999) 1903-1908
45. Hendry P.J., Masters R.G., Mussivand T.V., et al. Circulatory support for cardiogenic shock due to acute myocardial infarction. a Canadian experience. Can J Cardiol 15 (1999) 1090-1094
46. Anderson H., Steimle C., Shapiro M., et al. Extracorporeal life support for adult cardiorespiratory failure. Surgery 114 (1993) 161-173
47. Smedira N.G., and Blackstone E.H. Postcardiotomy mechanical support. risk factors and outcomes. Ann Thorac Surg 71 suppl 3 (2001) S60-S66
48. Pagani F.D., Lynch W., Swaniker F., et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant. a strategy to optimize survival and resource utilization. Circulation 100 suppl 19 (1999) II-206-II-210